Dr Erasmus G Morfe, DO | |
7780 S Broadway Ste 350, Littleton, CO 80122 | |
(720) 996-1260 | |
(303) 586-2292 |
Full Name | Dr Erasmus G Morfe |
---|---|
Gender | Male |
Speciality | Physical Medicine And Rehabilitation |
Experience | 25 Years |
Location | 7780 S Broadway Ste 350, Littleton, Colorado |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1467545137 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207T00000X | Neurological Surgery | DR.0042282 (Colorado) | Secondary |
208100000X | Physical Medicine & Rehabilitation | 42282 (Colorado) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Littleton Adventist Hospital, Centura Health | Littleton, CO | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Portercare Adventist Health System | 0941110886 | 547 |
News Archive
Jazz Pharmaceuticals plc today announced U.S. commercial availability of Versacloz (clozapine, USP) oral suspension, the first and only oral suspension clozapine for severely ill treatment-resistant schizophrenia patients or those at risk of recurrent suicidal behavior with schizophrenia or schizoaffective disorder.
Sophia Genetics, the global leader in Data-Driven Medicine (DDM), announced today the signing of a new strategic partnership with Integrated DNA Technologies (IDT).
Introducing the Reposa Synergy by Alpine HC, an innovative hybrid mattress system that exemplifies synergy by combining exceptional comfort through specialist foams, with effective pressure distribution using integral air-foam cells. The end result? A superior pressure relieving experience for the user.
Consumer-directed health care (CDHC) - high-deductible plans often touted as the answer to spiraling health care costs - is not likely to curb health care costs, and could even worsen health outcomes by reducing patients' receipt of needed preventive care and care for chronic conditions, says a new report from The Commonwealth Fund.
Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, today announced 11 posters on entinostat, an oral, highly selective, class I histone deacetylase inhibitor, will be presented at the 102nd Annual American Association for Cancer Research meeting April 2 to April 6 in Orlando, FL.
› Verified 7 days ago
Entity Name | Portercare Adventist Health System |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1760761928 PECOS PAC ID: 0941110886 Enrollment ID: O20090115000327 |
News Archive
Jazz Pharmaceuticals plc today announced U.S. commercial availability of Versacloz (clozapine, USP) oral suspension, the first and only oral suspension clozapine for severely ill treatment-resistant schizophrenia patients or those at risk of recurrent suicidal behavior with schizophrenia or schizoaffective disorder.
Sophia Genetics, the global leader in Data-Driven Medicine (DDM), announced today the signing of a new strategic partnership with Integrated DNA Technologies (IDT).
Introducing the Reposa Synergy by Alpine HC, an innovative hybrid mattress system that exemplifies synergy by combining exceptional comfort through specialist foams, with effective pressure distribution using integral air-foam cells. The end result? A superior pressure relieving experience for the user.
Consumer-directed health care (CDHC) - high-deductible plans often touted as the answer to spiraling health care costs - is not likely to curb health care costs, and could even worsen health outcomes by reducing patients' receipt of needed preventive care and care for chronic conditions, says a new report from The Commonwealth Fund.
Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, today announced 11 posters on entinostat, an oral, highly selective, class I histone deacetylase inhibitor, will be presented at the 102nd Annual American Association for Cancer Research meeting April 2 to April 6 in Orlando, FL.
› Verified 7 days ago
Entity Name | Neurosurgery One Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1255681615 PECOS PAC ID: 8022269612 Enrollment ID: O20121107000531 |
News Archive
Jazz Pharmaceuticals plc today announced U.S. commercial availability of Versacloz (clozapine, USP) oral suspension, the first and only oral suspension clozapine for severely ill treatment-resistant schizophrenia patients or those at risk of recurrent suicidal behavior with schizophrenia or schizoaffective disorder.
Sophia Genetics, the global leader in Data-Driven Medicine (DDM), announced today the signing of a new strategic partnership with Integrated DNA Technologies (IDT).
Introducing the Reposa Synergy by Alpine HC, an innovative hybrid mattress system that exemplifies synergy by combining exceptional comfort through specialist foams, with effective pressure distribution using integral air-foam cells. The end result? A superior pressure relieving experience for the user.
Consumer-directed health care (CDHC) - high-deductible plans often touted as the answer to spiraling health care costs - is not likely to curb health care costs, and could even worsen health outcomes by reducing patients' receipt of needed preventive care and care for chronic conditions, says a new report from The Commonwealth Fund.
Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, today announced 11 posters on entinostat, an oral, highly selective, class I histone deacetylase inhibitor, will be presented at the 102nd Annual American Association for Cancer Research meeting April 2 to April 6 in Orlando, FL.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Erasmus G Morfe, DO Po Box 5693, Denver, CO 80217-5693 Ph: (303) 306-7783 | Dr Erasmus G Morfe, DO 7780 S Broadway Ste 350, Littleton, CO 80122 Ph: (720) 996-1260 |
News Archive
Jazz Pharmaceuticals plc today announced U.S. commercial availability of Versacloz (clozapine, USP) oral suspension, the first and only oral suspension clozapine for severely ill treatment-resistant schizophrenia patients or those at risk of recurrent suicidal behavior with schizophrenia or schizoaffective disorder.
Sophia Genetics, the global leader in Data-Driven Medicine (DDM), announced today the signing of a new strategic partnership with Integrated DNA Technologies (IDT).
Introducing the Reposa Synergy by Alpine HC, an innovative hybrid mattress system that exemplifies synergy by combining exceptional comfort through specialist foams, with effective pressure distribution using integral air-foam cells. The end result? A superior pressure relieving experience for the user.
Consumer-directed health care (CDHC) - high-deductible plans often touted as the answer to spiraling health care costs - is not likely to curb health care costs, and could even worsen health outcomes by reducing patients' receipt of needed preventive care and care for chronic conditions, says a new report from The Commonwealth Fund.
Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, today announced 11 posters on entinostat, an oral, highly selective, class I histone deacetylase inhibitor, will be presented at the 102nd Annual American Association for Cancer Research meeting April 2 to April 6 in Orlando, FL.
› Verified 7 days ago
Dr. Eric Michael Shoemaker, DO Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 7720 S Broadway Ste 310, Littleton, CO 80122 Phone: 303-584-5844 Fax: 303-256-9717 | |
Esther Yoon, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 7780 S Broadway Ste 350, Littleton, CO 80122 Phone: 720-638-7500 Fax: 720-583-6770 | |
Brendan Joseph Polun, DO Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1001 W Mineral Ave, Littleton, CO 80120 Phone: 719-457-6200 | |
Brian Alan Miller, D.O Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1001 W Mineral Ave, Littleton, CO 80120 Phone: 719-457-6200 Fax: 303-363-5142 | |
Jason Michael Peragine, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 7780 S Broadway Ste 350, Littleton, CO 80122 Phone: 720-638-7500 Fax: 720-583-6770 | |
Kyleigh Rubow, MPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 9279 Star Streak Cir, Littleton, CO 80125 Phone: 916-600-4949 | |
Ashley Nicole Maes, DPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 5822 S Lowell Way, Littleton, CO 80123 Phone: 720-409-5605 |